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ABSTRACT
Retinoid X receptor (RXR) is an obligate het-
erodimeric partner of several nuclear receptors
(NRs), and as such a central component of NR sig-
naling regulating the immune and metabolic phe-
notype of macrophages. Importantly, the binding
motifs of RXR heterodimers are enriched in the
tissue-selective open chromatin regions of resident
macrophages, suggesting roles in subtype specifi-
cation. Recent genome-wide studies revealed that
RXR binds to thousands of sites in the genome,
but the mechanistic details how the cistrome is es-
tablished and serves ligand-induced transcriptional
activity remained elusive. Here we show that IL-4-
mediated macrophage plasticity results in a greatly
extended RXR cistrome via both direct and indirect
actions of the transcription factor STAT6. Activation
of STAT6 leads to chromatin remodeling and RXR re-
cruitment to de novo enhancers. In addition, STAT6
triggers a secondary transcription factor wave, in-
cluding PPAR. PPAR appears to be indispens-
able for the development of RXR-bound de novo
enhancers, whose activities can be modulated by
the ligands of the PPAR:RXR heterodimer confer-
ring ligand selective cellular responses. Collectively,
these data reveal the mechanisms leading to the dy-
namic extension of the RXR cistrome and identify
the lipid-sensing enhancer sets responsible for the
appearance of ligand-preferred gene signatures in
alternatively polarized macrophages.
INTRODUCTION
RetinoidX receptor (RXR) is a unique and enigmatic mem-
ber of the nuclear receptor superfamily due to its het-
erodimerization capacity with several different nuclear re-
ceptors (1). This widespread dimerization capacity of RXR
puts this receptor on the crossroads of nuclear receptor-
mediated transcriptional regulation, but at the same time
it also harbors independent regulatory roles (1–3). RXR
has indispensable roles during prenatal development (4,5).
Furthermore, drugs targeting RXR are in use for cancer
therapy and others are in preclinical trials to tackle in-
sulin resistance and atherosclerosis (6,7). Recently, there
have been emerging pieces of evidence pointing to the sig-
nificance of RXR in modulating the immunological state
of macrophages (8–10). To date, several studies report
about the multifaceted roles of macrophage RXR in con-
trolling autoimmune disease, the phagocytic capacity of
macrophages, the clearance of amyloid- by brain mi-
croglia in an Alzheimer’s disease model and leukocyte mi-
gration (8,10). According to these studies, there seems to
be a consensus that RXRs are important regulators of
macrophage function. In addition, open chromatin land-
scapes of tissue-resident macrophages revealed the enrich-
ment of RXR heterodimer-binding motifs at the accessi-
ble chromatin regions of the cells in a tissue-selective man-
ner (11,12). There are only a few established examples of
causative relationships betweenNRs andmacrophage spec-
ification. It has been shown that in the absence of LXR
(13) and PPAR (14), the size of spleen- and lung-resident
macrophage populations is greatly diminished, respectively.
Interestingly, these studies indicate that the appearance of
specific RXR heterodimers are defining features of tissue-
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resident macrophage subtypes, but the molecular triggers
and mechanisms mediating the development of these are
not known. RXR is part of the heterodimeric NR family
and their behavior is different than that of homodimeric,
steroid NRs such as ER and GR. The cistromes of steroid
receptors are principally driven by ligand binding, which
triggers their rapid translocation to the nucleus leading to
tens of thousands of de novo, receptor-bound sites in the
genome. Counter to this mechanism, RXR heterodimers
are considered to be genome-bound molecular switches, re-
pressing transcription in the absence of their ligands, which
case can be reversed to an active state once the activating lig-
and is present, known as the ‘molecular switch model’ (45).
This model implies that most if not all chromatin bound re-
ceptors act as switches flipped by ligand.
Recent studies reported that the enhancer repertoire
of macrophages are dynamically rearranged by the two
main signal-dependent transcription factors (SDTFs) (in-
terleukin 4 (IL-4)-activated STAT6 or Kdo(2)-lipid A
(KLA)-activated NF-B) controlling classical and alter-
native macrophage polarization (15). The fact that these
can take place in terminally differentiated cells indicates
that cell type-specific gene expression patterns can be re-
arranged (16,17). Therefore, we hypothesized that upon
macrophage polarization, RXR-bound regulatory regions
are reprogrammed in order to support the changed signal-
ing requirements.
Recently, it has been shown that RXR heterodimers are
able to act on the pre-determined enhancer landscape of
macrophages occupied by LDTFs (3,18,19). However, sig-
nals initiating the establishment, rearrangement and main-
tenance of NR cistromes remain elusive in the context
of RXR heterodimers. Our recent study in non-polarized
macrophages show that ligand stimulation does not signif-
icantly affect the genomic distribution of RXR, suggest-
ing that RXR heterodimers behave in a rather static way if
compared to steroid receptors, which rapidly occupy thou-
sands of sites in the genome upon ligand binding (3). These
observations raise the questions how such RXRs function
and what type of mechanistic pathways may play roles in
the deposition and redistribution of the receptor in the
macrophage genome.
In this study, we have investigated the behavior of the
RXR cistrome upon alternative macrophage polarization.
Genome-wide characterization of RXR binding revealed a
substantially extended RXR cistrome. We show that IL-4-
activated STAT6 drives the extension of the RXR cistrome
in a PPAR -dependent manner in the vast majority of the
cases. Systematic assessment of open chromatin structure
and the binding sites of STAT6, PU.1, RXR, PPAR , P300
and RAD21 revealed the kinetics and the epigenomic de-
terminants of de novo RXR-bound regulatory sites. Fur-
thermore, PPAR :RXR heterodimers are required for the
proper development of the polarization-specific open chro-
matin landscape. Genome-wide mapping of RNAPII-pS2
in the presence of the specific ligands, rosiglitazone (RSG)
and LG100268 (LG268), allowed us to functionally charac-
terize the PPAR :RXR-bound enhancer-gene network and
pinpoint the dominant/selective effects of these ligands.
MATERIALS AND METHODS
Materials
Ligands: LG268 (Sigma), RSG (Sigma), mIL-4 (Pepro-
tech).
Mouse strains
All strains are on C57BL/6 genetic background. The RXR-
deficientmacrophage-specific knockoutmicewere gifts from
Pierre Chambon’s laboratory. We crossed Rxra fl/fl Rxrb
+/− lysozyme-Cre (LysCre)+ males with Rxra fl/fl Rxrb
−/− LysCre+ females and used the Rxra fl/fl Rxrb −/−
LysCre+ 3 months old male mice.
Mice carrying null or floxed alleles of Pparg were created
as described previously (20). These mice were backcrossed
to the C57BL/6J strain for eight generations. Mice were
bred with LysCre transgene animals to create the following
genotypes: Pparg +/+ LysCre+, Pparg fl/fl LysCre+, Pparg
+/− LysCre+ and Pparg fl/- LysCre+.
Stat6 KO is a full body knockout, and it was obtained
from Jackson laboratories. In this case we maintained them
homozygous for Stat6 ablation and we mated knockout
male with female mice. For all of our experiments using
knockout cells, we used C57BL/6 wild type male mice.
Differentiation of bone marrow-derived macrophages
Isolation and differentiation were completed as described
earlier (3). Isolated bone marrow-derived cells were differ-
entiated for 6 days in the presence of L929 supernatant.
Cells were either exposed to IL-4 (5 ng/ml) during thewhole
differentiation process or polarized on the sixth day of the
differentiation with IL-4 (20 ng/ml) for the indicated period
of time.
Immortalization of mouse bonemarrow-derivedmacrophages
Bone marrow-derived cells were immortalized using the J2
cell line continuously producing the J2 virus encoding v-raf
and v-myc oncogenes (21). J2 cells were grown in DMEM
containing 20% FBS. Bone marrow cells were seeded in im-
mortalization media I (90% J2 supernatant, 5% HyClone
FBS, 10 ug/ml Polybrene 0.1%, L929 supernatant 5%) and
incubated overnight. On the second day, supernatant was
collected and spun down to pellet floating cells. Adherent
cells were scraped and re-plated into a new petri dish us-
ing immortalization media II (20% J2 supernatant, 10%
HyClone FBS, 10ug/ml Polybrene 0.1%, L929 supernatant
10%, 60% DMEM) and incubated for 6 days. After the im-
mortalization, cells were kept in regular macrophage differ-
entiation media (20% FBS, 30% L929 supernatant and 50%
DMEM containing 1% antibiotics).
Treatment conditions
Primary macrophages were treated with IL-4 (5ng/ml) for
6 days during long-term exposure. Upon short-term expo-
sure macrophages were treated with IL-4 (20 ng/ml) for 1,
6 and 24 h. These treatment conditions were used forChIP-
seq. RNAPII-pS2 ChIP-seq and gene expression measure-
ments were performed in macrophages differentiated with
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M-CSF, on the 6th day cells were exposed to IL-4 (20 ng/ul)
for 24 h. After 24 h of polarization, LG268 (100 nM) and
RSG (1 uM) were added to the cells for an additional 1 h.
ATAC-seq experiments were carried out in the short-term
and long-term exposure system using the IL-4 concentra-
tions described above. GRO-seq experiments were carried
out after 24 h of IL-4 (20 ng/ul) treatment followed by 1 h
of ligand exposure (LG268 100 nM, RSG 1 uM).
Real-Time Quantitative PCRfor enhancer RNA and mRNA
detection (qPCR)
RNA was isolated with Trizol reagent (Ambion). RNA
was reverse transcribed with High-Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems) according to
manufacturer’s protocol. Transcript quantification was per-
formed by qPCR reactions using SYBR green master mix
(BioRad). Transcript levels were normalized to Ppia.
Assay for transposase accessible chromatin with high-
throughput sequencing (ATAC-seq)
ATAC-seq was carried out as described earlier with mi-
nor modification (22). Cells were scraped and counted to
achieve 50k/ml in ice-cold PBS. Cell suspension was fur-
ther diluted to 25k/ml and nuclei were isolated with ATAC-
LB (10 mM Tris–HCl pH 7.4, 10 mMNaCl, 3 mMMgCl2,
0.1% IGEPAL). Nuclei from 25k cells were used for tag-
mentation using Nextera DNALibrary Preparation Kit (Il-
lumina) from two biological replicates. After tagmentation
DNAwas purified withMinelute PCR PurificationKit (Qi-
agen). Tagmented DNA was amplified with Kapa Hifi Hot
Start Kit (Kapa Biosystems) using 9 PCR cycles. Ampli-
fied libraries were purified again withMinelute PCR Purifi-
cation Kit. Fragment distribution of libraries was assessed
with Agilent Bioanalyzer and libraries were sequenced on a
HiSeq 2500 platform.
ATAC-seq analysis
The primary analysis of ATAC-seq-derived raw sequence
reads has been carried out using the updated version of
our ChIP-seq analysis command line pipeline (46) includ-
ing the following steps: Alignment to the mm10 mouse
genome assembly was done by the BWA tool (23), and
BAM files were created by SAMTools (24). Fragment
length was set uniformly to 120 nts by makeTagDirectory
(HOMER). Genome coverage (bedgraph) files were gen-
erated by makeUCSCfile.pl (HOMER) (18), converted to
TDF files by IGVtools, and then visualized with IGV2 (25).
Read densities for read distribution heat maps were gener-
ated by annotatePeaks.pl (HOMER), median normalized
based on a consensus set generated from those peaks de-
tected from at least two samples of all used for the given
comparison and visualized by Java TreeView (47). Cover-
age values of the summits were used for box plots.
ChIP (chromatin immunoprecipitation)
ChIP was performed essentially as previously described
(26). Libraries were prepared either with Ovation Ultralow
Library Systems (Nugen) or TruSeq ChIP library systems
(Illumina) according to the manufacturer’s instructions.
The following antibodies were used: IgG (Millipore, 12–
370), RXR (sc-774), P300 (sc-585), PU.1 (sc-352), RAD21
(ab992), STAT6 (sc-981), PPARG (Perseus #PP-A3409A)
and RNAPII-pS2 (ab5095).
ChIP-seq analysis
The primary analysis of ChIP-seq-derived raw sequence
reads has been carried out similarly as described for the
ATAC-seq analysis. Peaks were predicted by MACS2 (27),
and artifacts were removed according to the blacklist of
ENCODE (48). Three RXR ChIP-seq replicates derived
from those BMDMs differentiated in the presence or ab-
sence of IL-4 were analyzed by DiffBind (28) using an in-
put control: consensus peak set was formed from those
peaks predicted from at least two of six samples. Peaks
showing significant increase upon IL-4 treatment (P>0.05)
and those without significant increase were further divided
based on their presence in Stat6KO BMDM cells. The me-
dian summit coverage value of the cluster showing no dif-
ference between the three conditions (Cl3) was the basis of
the normalization of read coverage on both the read dis-
tribution heat maps and box plots (in the cases of RXR,
PU.1, P300, RAD21 and RNAPII-pS2). The de novo RXR
peak set (Cl2) was further divided based on the presence
of STAT6 peaks upon 1h of IL-4 treatment. These subdi-
visions then were further separated and analyzed by the
PPAR -dependent peaks (not present inPpargKO) and in-
dependent RXR peaks (present in Pparg KO).
RNAPII-pS2 abundance on gene bodies (using mm10
RefSeq annotation) was quantified and tested using pack-
age Rsubread and edgeR (P ≤ 0.05 and FC ≥ 2.0), respec-
tively. Metagene plots were created using ngs.plot (49) soft-
ware.
Motif analysis
The middle 100-bp regions of the up to 1000 top peaks
were used formotif enrichment analyses, performed by find-
MotifsGenome.pl (HOMER). P-values were calculated by
comparing the target region enrichments with those of an
about 50 000-region random (background) set generated by
HOMER. The selected motif matrices (Figure S1A) were
mapped by annotatePeaks.pl (HOMER). Box plot and bar
graph was used to represent motif score distribution. Mo-
tif appearances counted in 30-bp windows within 1.5 kb
around the chosen regions were determined by using in-
tersectBed (BEDTools) and other command line programs,
and then were plotted by java TreeView. Sequence of the
top DR1 motif (±16 bp) for each selected RXR/PPARg-
bound region (within 200 bp)was recovered by ‘homerTools
extract’ and to color sequences, each nucleotides were ex-
changed to a number (–1, 0 or 1) or ‘x’ (NA). Based on the
generated matrix, sequence heat maps were visualized by
Java TreeView. Nucleotide frequencies within the annotated
peak/DR1 groups were converted to Homer motif matrices
with command line tools, and then were visualized by mo-
tif2Logo.pl (HOMER).
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SubTAD prediction
The insulator motif matrix determined from the top 1000
CTCF peak summits that overlapped with RAD21 peaks
(insulator regions) was mapped onto the 200-bp region
around CTCF summits, and the top hit for each region was
designated as an insulator element. RPKM values for both
CTCF and RAD21 ChIP-seq samples (3) were calculated
on the 100-bp region around insulators, and those regions
showing higher density for both proteins than the 100 000th
of the summed density of all regions were used for subTAD
prediction. The closest insulators showing convergent direc-
tion within a 1-Mb distance but farther than 1 kb were as-
signed to each other and called subTADs if their coverage
showed less than a 2-fold difference for both proteins. In the
case of overlapping subTADs, those were kept having the
highest insulator coverage. ‘Negative’ subTADs with diver-
gent insulators were defined in the same way as convergent
ones.
Global Run-On sequencing (GRO-seq)
GRO and library preparation were performed as described
earlier (3) with the following modifications: Libraries were
generated from two biological replicates using NEBNext
Small RNA Library Prep set for Illumina. Bone marrow-
derived macrophages were polarized with IL-4 for 24 h or
left untreated, then cells were exposed to RSG, LG268 or
Veh (vehicle - DMSO:Ethanol) for one additional hour.
Fragment distribution of libraries was assessed with Agi-
lent Bioanalyzer and libraries were sequenced on a HiSeq
2500 platform.
GRO-seq analysis
The primary analysis of GRO-seq-derived raw sequence
reads has been carried out similarly as described for the
ATAC-seq analysis. The upper decile-normalized RPKM
values calculated from the unique reads on protein-coding
genes were compared between the three conditions (Veh,
RSG and LG268 treatment) examined by both GRO-seq
and RNAPII-pS2 ChIP-seq methods. Correlation coeffi-
cients were calculated based on the differentially expressed
genes between the three conditions.
Enhancer analysis
TSSs of ligand-responsive genes and PPAR :RXR ‘co-
peaks’ within the same subTAD were assigned to each
other. Average RNAPII-pS2 densities within the 2-kb re-
gion around the annotated peaks were determined by an-
notatePeaks.pl (HOMER) and visualized as box plots. Fold
changes upon ligand treatments were shown on scatter
plots.
Western Blot
Whole cell lysates were resolved by electrophoresis in 10%
polyacrylamide gel and then transferred to Immobilon-P
Transfer Membrane. Membranes were probed with anti-
PPAR (81B8) and anti-RXR (sc-553) antibodies accord-
ing to manufacturer’s recommendations.
Statistical tests
QPCR measurements were presented as means ± SD. We
made at least two biological replicates; performed unpaired
(two-tailed) t tests and the differences were considered sig-
nificant at P < 0.05. ChIP-seq densities presented in box
plots are analyzed with (two-tailed) paired t-test. Differ-
ences were considered significant at P < 0.0001.
Availability of sequencing data sets
Sequencing data have been submitted to GEO under acces-
sion number: GSE110465.
RESULTS
IL-4-activated STAT6 is required for the extension of the
RXR cistrome in alternatively polarized macrophages
In order to investigate whether and how alternative
macrophage polarization impacts the RXR cistrome,
we utilized mouse bone marrow-derived macrophages
(BMDMs) differentiated in the presence of IL-4 (Figure
1A). Chromatin immunoprecipitation followed by sequenc-
ing (ChIP-seq) for RXR revealed an extensively remodeled
and expandedRXR-bound set of genomic regions upon IL-
4 stimulation. The magnitude of the expansion prompted
us to address the contribution of STAT6 to this process.
In order to dissect this aspect we used STAT6-deficient
macrophages from Stat6 knockout (S6KO) animals. Using
ChIP-seq experiments we determined the RXR cistrome
in S6KO macrophages and clustered the RXR-bound re-
gions based on their IL-4 and STAT6 dependence (Figure
1B). This analysis yielded four major RXR clusters: Clus-
ter 1 (Cl1) contains those regions having slight induction in
the presence of IL-4 and exhibit strong STAT6-dependence;
Cluster 2 (Cl2) has de novo RXR-bound regulatory regions
and complete IL-4/STAT6-dependence; Cluster 3 (Cl3) in-
cludes regions unaffected by IL-4/STAT6; and Cluster 4
(Cl4) is similar to Cl2 with regards to the IL-4-induced
RXR deposition, but its component regions exhibited a
lower level of STAT6-dependence (Figure 1B–D). De novo
motif enrichment analysis of the four clusters reported the
presence of the expected macrophage-specific transcription
factor motifs, for instance PU.1, C/EBP, TRE (AP-1) and
RUNX (Supplementary Figure S1A). Importantly, we ob-
served marked differences between Cl2 and Cl3, specifically
that Cl2 displayed robust enrichment for the direct repeat
1 (DR1) motif indicating that likely PPAR is the predom-
inant partner of RXR at these sites, while in Cl3, nuclear
receptor (NR) half sites dominate with some enrichment
for DR4 (specific for e.g. LXR:RXR heterodimers). Cl1
showed similar results to those of Cl3, and the results of Cl4
were similar to those of Cl2 (Supplementary Figure S1A).
Importantly, we observed the enrichment of the EGR2 mo-
tif in Cl2 and Cl4, which has been described as a transcrip-
tion factor induced upon alternative macrophage polariza-
tion (29,30). Mapping the matrices of the enriched mo-
tifs provided a more detailed picture about motif distribu-
tion (Figure 1B, Supplementary Figure S1B). NR half sites
were enriched near all RXR-bound regions, and the puta-
tive STAT6 elements showed a low enrichment in the IL-
4/STAT6-dependent Cl2. DR1 showed the expected high
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Figure 1. Alternatively polarized macrophages greatly extend their RXR cistrome in an IL-4/STAT6-dependent manner. (A) Model system used to achieve
alternative macrophage polarization. (B) Read distribution plots of RXR ChIP-seq signal intensities in wild type (WT) and Stat6 knockout (S6KO)
macrophages either left untreated (–) or treated with IL-4 (+) (left). Clusters were discriminated based on IL-4 responsiveness and STAT6 dependence,
and the number of genomic regions within them is indicated (middle). Distribution of DR1 and PU.1 motifs around RXR peaks (right). 1.5-kb regions
are represented in 30-bp bins. (C) Box plot depicting the normalized tag density for each RXR clusters as shown on panel B. Significant differences are
indicated with asterisks, determined by two-tailed paired t test, P < 0.0001. (D) Genome browser view about the RXR-bound genomic regions on the
Abcg1 locus under the indicated conditions. Arrows indicate de novo RXR-bound regulatory regions, exhibiting STAT6 dependence.
frequency in both clusters 2 and 4, but there were DR1 sites
scattered also in the other two clusters. TREs showed sim-
ilar distribution as DR1s, but EGR2 motifs had a higher
frequency in the de novo cluster. In contrast, a high abun-
dance of putative PU.1 elements could be observed in clus-
ters 1 and 3, and fewer hits were found in Cl2 (Figure 1B
and Supplementary Figure S1B), indicating that beside the
LDTF PU.1 and the SDTF STAT6, other transcription fac-
tors also have major roles in Cl2, including PPAR .
Altogether, these results show that IL-4-polarized
macrophages have an extended RXR cistrome where
PPAR may be the dominant partner, and STAT6 is
indispensable in the development of this state.
Dynamic establishment of de novo RXR binding is initiated
by STAT6 and leads to PU.1, P300, RAD21 recruitment and
chromatin opening
Regarding the extensive effect of IL-4 on the RXR
cistrome during macrophage differentiation, we were won-
dering about the dynamics and epigenomic features of
this rearrangement. To test these, we applied time-course
experiments upon the IL-4 treatment of differentiated
macrophages and determined the chromatin accessibility
(ATAC-seq) and the binding of STAT6, RXR, PU.1, P300
(universal co-activator, active enhancer mark) and RAD21
(genome architectural protein) by ChIP-seq at the 0, 1, 6
and 24-h time points (Figure 2A). Overlaying the RXR
clusters (as shown on Figure 1) with the time-course data
sets revealed robust changes in Cl2, while the other clus-
ters did not exhibit major differences, except for the binding
of STAT6, which got elevated upon IL-4 stimulation in all
clusters (Figure 2B, Supplementary Figure S2A). Therefore
we focused our attention to the most dynamically changing,
de novo RXR cluster (Cl2).
Assessment of chromatin accessibility shed light on the
progressively opening nature of these genomic regions in
time. This observation could be explained by our ChIP-
seq data sets, showing that all the investigated factors were
recruited to these sites upon IL-4 stimulation, although
with slightly different binding kinetics (Figure 2B). More
precisely, STAT6 recruitment was the first indicator of en-
hancer activation, which was followed by RXR, PU.1, P300
and RAD21 binding. Investigation of the enrichment of the
elongation-specific RNA polymerase II phosphorylated on
serine 2 (RNAPII-pS2) revealed that the majority of these
sites should be considered active enhancers. In addition, we
selected five de novoRXR-bound genomic regions andmea-
sured enhancer RNA levels. Three out of the five showed
significantly induced enhancer transcription in the presence
of IL-4 (Supplementary Figure S2B).
After providing a genome-wide and temporal view of
this process, we went on to validate these findings on two
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Figure 2. Characterization of the epigenomic components of RXR-bound regulatory regions upon macrophage polarization. (A) Scheme of the model
system used to study the dynamic features of the RXR cistrome extension and other transcription factors’ binding kinetics using a time-course upon IL-4
exposure. (B) Read distribution plot of ATAC-seq signals (chromatin accessibility) and ChIP-seq intensities for STAT6, RXR, PU.1, P300, RAD21 and
RNAPII-pS2 at the indicated time-course of IL-4 stimulation in wild type macrophages (h, hours). Clusters established on Figure 1 panel B are represented
for each experiment, and the number of genomic regions within each cluster is indicated. 1.5-kb regions are represented in 30-bp bins. (C) Genome browser
views of ATAC-seq and ChIP-seq read enrichments for the presented factors in the presence of IL-4 for the indicated period of time on the Abcg1 and
Tgm2 loci. Arrows indicate the enhancers of Abcg1 and Tgm2 located –22 kb and –20 kb from the transcription start site of the genes, respectively. Dashed
lines indicate the transcription start sites, and the arrowhead on the lines indicates the direction of the genes. ChIP-qPCR experiments performed on the
two enhancers for the indicated factors are also presented next to the genome browser images using a time-course of IL-4 stimulation.
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individual enhancers on the Abcg1 and Tgm2-associated
genomic regions (Abcg1 -22 kb, Tgm2 -20 kb). Using
H3K4me2 as a general regulatory element mark we ob-
served a similar, continuous signal increment as with
ATAC-seq, and the binding patterns of STAT6, RXR,
P300, RAD21 and PolII revealed similar recruitment
modalities as observed in the ChIP-seq data sets (Figure
2C). Based on these results, we noted a slight difference in
the kinetics of RXR and P300 recruitment at the two mea-
sured genomic regions, which may suggest that there are
different mechanisms for the reprogramming of the RXR
cistrome. An additional observation, which further sup-
ports this view, is the weaker occupancy of STAT6 in Cl2
if compared to the other clusters (Supplementary Figure
S2A), suggesting that the STAT6-mediated direct and indi-
rect means control the remodeling of the RXR-bound reg-
ulatory regions.
The formation of de novo RXR-bound regulatory elements
are STAT6-dependent, but only partially occupied by STAT6
Our previous results indicated that there are likely to be
direct and also indirect STAT6 effects that are contribut-
ing to the development of the de novo RXR-bound ge-
nomic regions (Cl2). Therefore, we decided to investigate
STAT6 binding in Cl2, which revealed that out of the 2554
sites, only 26% (655) were bound by STAT6 (Figure 3A–C).
Overlaying the binding kinetics of RXR, PU.1, P300 and
RAD21 with the STAT6 positive and negative RXR clus-
ters from the time-course experiments revealed that these
factors followed the recruitment of STAT6 as early as 1 h
after stimulation unlike STAT6 negative RXR sites, which
appeared to recruit the receptor and the additional fac-
tors after 6 h of stimulation (Figure 3B). A similar phe-
nomenon was observed in chromatin openness, namely that
STAT6-bound genomic regions are more accessible at the
basal state than those showing a prolonged opening dy-
namics, and IL-4/STAT6 is able to further open these sites
and contribute to the maintenance of this chromatin sta-
tus probably by secondary effects (Supplementary Figure
S3A). In addition, STAT6 positive sites readily-bound by
PU.1, P300 and RAD21 at the basal state, further increase
the presence of these factors upon IL-4 stimulation. Sorting
the motif distribution plots accordingly, we observed that
STAT6 binds exclusively to its specific elements, and PU.1
has higher motif enrichment in the STAT6-bound regions
(Figure 3A, Supplementary Figure S3B). This is probably
also due to the sequence similarity between the two motifs
as the ETS core motif (GGAA) might serve as a half site of
STAT6. DR1, in contrast, shows enrichment in the STAT6
negative RXR sites, which, in light of the induced PPAR
protein level upon IL-4 treatment (Supplementary Figure
S3C), may explain the shift in the dynamics of protein bind-
ing events (Figure 3A and B). A de novo motif enrichment
analysis also resulted in the notion that there is a partial
exclusion between STAT6 and DR1 elements, and there are
additional transcription factors, which contribute to the ac-
tivation of de novo RXR-bound enhancers (Figure 3D).
Collectively, these results indicate that the remodeling of
the RXR binding landscape is accomplished by STAT6-
initiated and mediated direct and indirect effects, and
PPAR , among other factors (AP-1, EGR2), likely to have
critical roles in this process.
STAT6-induced PPAR is required for the extension of the
RXR cistrome and the heterodimer is needed for chromatin
remodeling
Along the lines of our observations made above, we in-
tended to study how PPAR contributes to the extension
of the RXR cistrome. This is important in order to under-
stand the development of the cistrome, because RXR pro-
tein levels are not changing whilst, as it has been described
and we confirm here, PPAR levels showed robust up-
regulation upon alternative macrophage polarization (31–
33), underscoring its possible contribution to RXR redis-
tribution (Supplementary Figure S3C). Using ChIP-seq for
RXR in Pparg KO (PKO) macrophages revealed that a
significant part (1697 sites, 66%, Groups 2 and 4) of the de
novoRXR sites cannot be established by IL-4 in the absence
of PPAR (Figure 4A and B). Using ATAC-seq in RxrKO
and PKO macrophages we found that both nuclear re-
ceptors contribute to chromatin opening. More specifically,
sites that showed PPAR -dependent RXR binding but no
STAT6 recruitment (Group 4) exhibited the highest neces-
sity of the presence of PPAR :RXR to become fully opened
(Figure 4A and C; see control set on Supplementary Figure
S4A). Group 3 was less dependent on PPAR , and groups
1 and 2 were less dependent on RXR. Regarding the overall
openness, STAT6 binding sites without later PPAR bind-
ing (Group 1) are themost opened, and the originally closed
regions with later PPAR binding (Group 4) are the least
opened independent of IL-4 treatment. Motif distributions
indicate that only the PU.1 motif frequency follows this or-
der (Group 1 to 4), TRE is more or less equally distributed
throughout cluster 2, and interestingly, EGR2 motifs show
a negative correlation with PPAR dependency (Supple-
mentary Figure S4B). Although DR1 is not highly enriched
in Group 2, we still see a robust effect of PPAR on RXR
binding and this result is in agreement with the ATAC-seq
data in some ways (Figure 4A and C). As both KOs have
major effects on the genomic regions in Group 4, we can as-
sume that this is due to the high frequency of DR1 elements
and the direct DNA-binding by the receptors. In contrast,
in Group 2 we can probably see indirect binding events to a
greater extent.
These results prompted us to carry out ChIP-qPCR ex-
periments to validate and study the relationship between
RXR, PPAR and STAT6 at individual enhancers using
Rxra/b, Pparg and Stat6 KO immortalized bone marrow-
derivedmacrophages (iBMDMs). ChIP-qPCR experiments
on a select set of enhancers (Angptl4 +2.2 kb, Tgm2 –20
kb, Abcg1 –22 kb, Fabp4 –5.3 kb and Pou5f1 –2.9 kb) re-
vealed that the IL-4-mediated recruitment of PPAR and
RXR is completely dependent on STAT6. The receptors’ re-
cruitment also exhibitedmutual dependence on each other’s
presence, but PPAR binding was less sensitive to the ab-
sence of RXR (Figure 4D). Finally, investigation of the to-
tal RXR protein levels inPpargKOmacrophages revealed
that the loss of Pparg does not affect RXR expression at
the protein level (Supplementary Figure S4D).
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Figure 3. Extension of the RXR cistrome is carried out by the direct and indirect actions of STAT6. (A) Read distribution plots of the indicated ChIP-seq
experiments in the de novo, IL-4/STAT6-dependent RXR cluster (Cluster2 defined on Figure 1 panel B) separated based on STAT6 binding (h, hours).
The number of genomic regions within the STAT6 positive and negative RXR sub-clusters is indicated. Distribution of STAT6, DR1 and PU.1 motifs
around RXR peaks (right). 1.5-kb regions are represented in 30-bp bins. (B) Box plots depicting the normalized tag density for the indicated factors in the
STAT6 positive and negative RXR clusters. Significant differences were determined by two-tailed paired t test at P< 0.0001 and indicated by asterisks. (C)
Genome browser view of examples for STAT6 positive (1–4.) and negative RXR sites (5–8.): 1. chr18:88820090–88820456, 2. chr8:46868575–46869011,
3. chr11:70114345–70114844, 4. chr11:70114345–70114864, 5. chr15:10869138–10869551, 6. chr2:134730555–134731000, 7. chr15:10869138–10869551, 8.
chr15:10758849–10759232. (D)De novomotif enrichments in the STAT6 positive and negative RXR sub-clusters. Motif logos, names and the P-values are
indicated for each motifs enriched during the analysis.
Altogether, these results establish a hierarchy between
these factors and show that PPAR is a major component
in the extension of the RXR cistrome, though other mech-
anisms triggered by STAT6 may also play significant roles.
Loss of Rxra/b does not affect alternative polarization on a
select set of genes
Since our ATAC-seq results indicated that RXR/ pro-
teins affect chromatin structure, we made an attempt to
elucidate whether RXR has a prominent role in the IL-
4/STAT6-mediated induction of a select set of M2 polar-
izationmarker genes based on recent reports ofmacrophage
polarization (29,30). We polarized primary BMDMs from
WT and Rxra/b KO bone marrows and exposed the cells
to IL-4 for 24 h. We did not find significant differences
in the IL-4-induced expression of Chil3, Irf4, Klf4, Mrc1,
Egr2 and Batf3, but we observed significantly lower Retnla
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Figure 4. The appearance of PPAR is a major component in the genome-wide redistribution of RXR. (A) Read distribution plots of RXR and PPAR
signals from wild type (WT) and Pparg knockout (PKO) macrophages in the presence (+) or absence (–) of IL-4 as determined by ChIP-seq (left).
RXR sub-clusters shown on Figure 3 panel A were further divided based on the dependence of RXR binding on the presence of PPAR (P -dep.)
and STAT6 binding (S6-bound). The number of genomic regions within the four groups (Groups 1–4) is indicated (middle). Read distribution plots of
ATAC-seq signals from wild type (WT), Rxr (RxrKO) and Pparg knockout (PKO) macrophages in the presence (+) or absence (–) of IL-4 (right). 1.5-kb
regions are represented in 30-bp bins. (B) Genome browser view of examples for PPAR -independent (1–5.) and PPAR -dependent RXR sites (6–10.):
1. chr18:88820090–88820456, 2. chr8:46868575–46869011, 3. chr11:70114345–70114844, 4. chr11:70114345–70114864, 5. chr17:35809550–35809982, 6.
chr9:72485489–72485854, 7. chr3:9556170–9556746, 8. chr13:113138467–113138843, 9. chr16:93732883–93733288, 10. chr2:134730555–134731000. (C)
Box plots depicting the normalized tag density of ATAC-seq data for each group in the de novo RXR cluster as shown on panel A. Percentages represent
the contribution of the knocked-out nuclear receptor to chromatin openness, calculated based on the median values for the IL-4-treated samples. (D) ChIP-
qPCR-based determination of the binding modalities of RXR (upper panel) and PPAR (bottom panel) in Rxra/b (RXR KO), Pparg (PKO) and Stat6
knockout (S6KO) macrophages in the presence or absence of IL-4. Asterisk represents significant difference determined by two-tailed unpaired t test at P<
0.05 (n = 2).
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mRNA expression in the absence of Rxra/b (Supplemen-
tary Figure S4E).
Altogether, we concluded that RXR/ is not required
for the proper induction of this M2 polarization-related
gene panel, but further, unbiased analyses are required to
clarify the role of the receptor in polarization in its entirety.
Identification of the ligand-activated gene network by
the PPAR:RXR heterodimer in alternatively polarized
macrophages
After providing mechanistic details of RXR redistribu-
tion throughout the genome, we aimed to identify the tar-
get genes of this extended regulatory network. Mapping
RNAPII-pS2 by ChIP-seq in the presence of LG268 (RXR
agonist) or RSG (PPAR agonist) revealed the affected
gene bodies. We grouped the significantly changing gene
bodies based on their ligand sensitivity, and created four
gene groups based on a fold change cut-off of two-fold
relative to the control cells. Genes exhibiting an at least
two-fold induction in the presence of the RXR or PPAR
ligand were considered preferentially responsive to LG268
(‘RXR ligand-preferred’, n = 31) or RSG (‘PPAR ligand-
preferred’, n = 41). If both ligands were able to drive the
gene body enrichment of RNAPII by at least two fold,
then those were termed ‘Permissive’ genes (n = 29) (Fig-
ure 5A, B). We also noted the presence of repressive ef-
fects by the ligands, but these were negligible in number
compared to the activated ones (‘Repressed’; n = 16) (Sup-
plementary Figure S5A). Gene body enrichment analysis
of RNAPII-pS2 further corroborated our findings (Fig-
ure 5C and Supplementary Figure S5B) along with our
Global Run-On sequencing (GRO-seq) results represent-
ing the nascent RNA level in the same treatment paradigm,
which positively correlates with the RNAPII-pS2 data on
the regulated genes (Figure Supplementary Figure S5C).
Furthermore, Ingenuity Pathway Analysis (IPA) revealed
the potential functional consequences of the activated and
repressed gene programs mediated by the various ligands
(Supplementary Figure S5D–G). Interestingly, permissive
genes appeared to be responsible for lipid uptake and con-
centration inside the cells, while preferentially RXR ligand-
mediated genes showed enrichment for the regulation of
cholesterol flux (Supplementary Figure S5D and E). In ad-
dition, preferentially PPAR ligand-regulated genes seem
to be responsible for beta-oxidation and the accumulation
of very long-chain fatty acids (Supplementary Figure S5F).
In contrast, genes repressed by LG268 appear to be regulat-
ing the migration and inflammatory responsiveness of the
cells (Supplementary Figure S5G). For validation purposes
we measured the expression of the following genes from
the ligand-activated gene groups in the presence of both
LG268 and RSG at the mRNA level: Permissive––Angptl4,
Cd36, Plin2, Cpt1a; RXR ligand-preferred––Abca1, Scd2,
Cxcl14, Abcg1; PPAR ligand-preferred––Fabp4, Sort1,
Cfa2t3. These analyses confirmed the ligand preference of
the gene groups we identified based on RNAPII-pS2 en-
richments and also confirmed that permissive genes are in-
deed exhibit sensitivity to both nuclear receptor ligands. Of
note, we observed antagonism between the two ligands in
the PPAR ligand-preferred group (Fabp4 and Cbfa2t3),
while RXR ligand-preferred genes do not show any signs
of permissiveness (Supplementary Figure S5D–F).
Our analyses identified the target gene bodies/networks
of ligand-mediated PPAR :RXR heterodimers and point
to the presence of preferential ligand effects by the recep-
tors, which appear to represent functionally distinct cellular
programs.
Mapping RNAPII-pS2 on PPAR:RXR-bound genomic el-
ements allows the identification of ligand-responsive het-
erodimers
Finally, we decided to annotate PPAR :RXR heterodimer-
bound regions to ligand-responsive genes. Using ChIP-seq
experiments for two main architectural proteins, CTCF
and RAD21, we predicted the sub-(topologically associat-
ing domain) (subTAD) structure of macrophages. We ap-
plied an algorithm that utilizes both the insulator cover-
age and direction, which have been shown recently as in-
dicators of topological domain borders (3,34,35). Next we
assigned all PPAR :RXR co-bound regulatory regions to
those genes falling into the same subTAD (Figure 6A).
As a result, we annotated 85 permissive, 72 RXR ligand-
preferred, 111 PPAR ligand-preferred and 52 repressed
PPAR :RXR-bound regulatory regions. Plotting the den-
sity of RNAPII-pS2 at these genomic loci almost fully re-
capitulated the changes we observed on the target gene
bodies except for enhancers preferring PPAR ligand-
activation, which exhibited an LG268-mediated induction
as well, but as expected these sites were still more respon-
sive to RSG (Figure 6B left, C). The repressive effects of
the ligands were not significant on the regulatory regions
near repressed genes, but they showed a trend towards re-
pressed RNAPII-pS2 binding (Figure 6B and Supplemen-
tary Figure S6A). The distribution and plotting of DR1
motif scores reported that the strongest motifs are located
within the highly permissive and PPAR ligand-preferred
sites, followed by the RXR ligand-preferred regions, and
the repressed regions possessed the weakest motifs (Figure
6B, Supplementary Figure S6B). Validation of the conse-
quences of altered RNAPII-pS2 enrichment on the various
ligand-responsive enhancer categories at the mRNA level
of target genes (Angptl4––permissive; Vegfa––RXR ligand-
preferred; Fabp4––PPAR ligand-preferred) showed that
the changing level of RNAPII-pS2 on the enhancers is a
reliable indicator of altered gene expression, moreover at
these genes we observed an enhanced ligand responsive-
ness in IL-4-stimulated cells, as a result of the reorganized
PPAR :RXR-bound regulatory regions (Figure 6C).
Motif enrichment analysis focusing on the DR1 mo-
tif revealed slight differences between the differentially
ligand-sensitive PPAR :RXR heterodimers. We noted the
presence of an extended DR1 motif at PPAR ligand-
dominated enhancers. These sites typically exhibit an ANT
extension on the PPAR side (5′) of the DR1. The RXR
side (3′) is more or less similar between the categories, al-
though it is weaker in the repressed group (Figure 6D).
Analysis of the binding of PPAR :RXR heterodimers in
the enhancer categories showed that ligand preference is
associated with higher occupancy for PPAR and RXR
on the PPAR and RXR ligand-preferred enhancers, re-
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Figure 5. Characterization of the genome-wide effects of ligand-responsive PPAR :RXR heterodimers in IL-4-polarized macrophages. (A) Heat maps
representing the significantly changed, ligand-sensitive genes. Ligand dominance was calculated based on a 2-fold cut-off threshold. Permissive genes show
an at least 2-fold induction to both ligands, while the RXR and PPAR ligand-preferred genes were induced by at least 2-fold only in the presence of
either ligand. (B) Genome browser views of permissive (Angptl4), RXR ligand-dominated (Tgm2) and PPAR ligand-preferred (Fabp4) genes. ChIP-seq
experiments for RXR, PPAR and the elongation-specific form of RNAPII (RNAPII-pS2) under the indicated conditions are shown. (C) Metagene plot
representation of RNAPII-pS2 signals on the gene bodies of permissive, RXR ligand-preferred and PPAR ligand-preferred gene groups defined on panel
A. Coverage is defined as read count per million mapped reads. Transcription start (TSS) and termination (TTS) sites are indicated.
spectively. Interestingly, PPAR ligand sensitivity and the
strength of binding followed the observed, extended DR1
motif, while RXR binding was largely invariant, except for
the repressed sites, which exhibited low occupancy for both
PPAR and RXR (Figure 6D). These results suggest that
the DNA sequence itself might have a deterministic role in
regulating ligand responsiveness, which needs to be further
investigated in future studies.
Finally, we were wondering about the localization of
these ligand-responsive enhancer categories with regards
to the clusters defined on Figure 1B. Surprisingly, ligand-
activated enhancers were the most enriched in Cl4 and the
least enriched in Cl1, while the repressed sites showed the
opposite distribution (Figure 6E). It is important to note
that de novoRXR sites in Cl2 do not seem to exhibit strong
ligand sensitive action.
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Figure 6. IL-4-mediated macrophage polarization allows the remodeling of enhancer activity in a PPAR :RXR heterodimer ligand-dependent manner.
(A) Genome browser view of the Abcg1 locus in order to represent the main features of our method to annotate enhancers to the gene groups defined on
Figure 5, panel A. ChIP-seq tracks are shown for CTCF, RAD21, RXR, PPAR and RNAPII-pS2. The predicted subTAD for this locus is presented,
with the direction of the CTCF elements (two red arrows). PPAR :RXR co-peaks are also shown. Dashed black line with an arrowhead represents the
transcription start site of Abcg1. (B) Box plot depicting normalized tag density on those enhancers annotated to the gene groups defined on Figure 5
panel A. The number of enhancers in each category is also indicated. Asterisk represents significant difference determined by two-tailed paired t test at
P< 0.0001 (left). Box plot representing DR1 motif scores in each enhancer category (right). (C) Scatter plots depicting RNAPII-pS2 signals on individual
enhancers from each enhancer group in the presence of rosiglitazone (RSG) and LG268. Cells were polarized with IL-4 for 24 h followed by 1 h of RXR-
(LG268) and PPAR -ligand (RSG) exposure. Log2 fold change over control is presented. Gene expression measurements of Angptl4, Vegfa and Fabp4
genes in control (CTR) and IL-4 polarized macrophages in the absence (ligand control – Veh) or presence of RSG or LG268. Asterisk represents significant
difference determined by two-tailed unpaired t test at P < 0.05 (n = 3). (D) Nucleotide distribution (N.D.) plots from each enhancer category in a 50-bp
window around the DR1motifs. Enriched DR1motifs are also indicated with the number of regions along with the normalized tag density for PPAR and
RXR in each enhancer category in the presence of IL-4 represented as boxplots and histograms. Normalized tag density on the histograms are represented
around the DR1 motif in a ±500 bp window (right). (E) Heat map depicting the enrichment of each enhancer groups in the clusters defined on Figure
1 panel B. (F) Graphical representation about the reorganization of the RXR cistrome and its ligand-sensitive action upon macrophage polarization.
IL-4 triggers the activation of STAT6, which upregulate Pparg. There is a significant RXR pool in the cells at the steady-state, which is not modulated
by IL-4 (left panel). During the polarization process, STAT6 directly (S6RE – STAT6 response element) initiates the formation of de novo regulatory
regions for the PPAR :RXR heterodimer (DR1 – direct repeat 1). The presence of PPAR is required for the extension of the RXR cistrome, but there
are secondary, unknown factors, which possess major roles binding to their response elements (grey box, RE). Yellow lightnings indicate the chromatin
opening capacity of the given factor and the size of the lightning indicates the effect of the factor on chromatin opening (middle panel). The extended
PPAR :RXR heterodimer exhibit different ligand sensitivity towards RSG and LG268, which will result in the activation and repression of functionally
distinct gene programs. Typically, de novo PPAR :RXR sites are not responsive to ligand, suggesting a significant, unknown receptor function, which
needs to be explored (right panel).
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These results indicate that ligand-sensitive receptor ac-
tion might be mediated by the genomic environment (se-
quence or epigenomic environment) and the redistribution
of RXR heterodimers does not necessarily give rise to ex-
ogenous ligand-operated genomic switches.
DISCUSSION
The development and signaling operations of heterodimeric
nuclear receptors are not well understood for the following
reasons (1) they bind chromatin and influence transcription
in the absence of ligand, (2) they bind as RXR heterodimers
allowing for distinct and complex ligand activation modes.
In this study we aimed to investigate the RXR-bound regu-
latory sites of alternatively polarized macrophages. The bi-
ological significance of our model is that IL-4-mediated po-
larization has a key role in anti-helminth defense (36) and
also in certain repair-type macrophages, including those re-
cently identified peritonealmacrophages responding to ster-
ile inflammation in the abdominal cavity, and tissue-specific
macrophages such as alveolar macrophages (37,38). At the
same time it appears that lipid ligand-regulated transcrip-
tion factors (NRs) also have key roles in macrophage func-
tion and potentially in cell type specification as well (11–14).
The biological importance of these NRs has been appreci-
ated due to their critical roles in lipid metabolism, immune
responses and also cellular differentiation (39). RXR acts as
a promiscuous heterodimerization partner of several NRs
and our previous results show that among others it controls
lipid metabolism (40) and angiogenesis (3), representing an
independent signaling pathway in resting macrophages. An
intriguing piece of observation from our previous study is
that the number of RXR-bound sites is not changing signif-
icantly upon ligand activation (3). This is in stark contrast
with how steroid hormone receptors function by occupy-
ing the genome rapidly in the presence of their ligands (41–
43). Our results bring novel mechanistic insights by showing
that the polarization process extensively remodels the RXR
cistrome and formally suggests that the RXR cistrome is
determined by the cellular state rather than the activating
ligand signal.
Molecularly, IL-4-activated STAT6 initiates the forma-
tion of the so-called de novo (17) or latent enhancers (16),
which serve as molecular beacons for the newly formed
RXR heterodimer signaling. Recently, a somewhat simi-
lar crosstalk has been identified between the inflammatory
signal induced NF-B and the ligand-dependent estrogen
receptor alpha (ER)-mediated signaling in breast cancer
cells, showing that inflammatory stimuli can pave the way
for estrogen signaling, establishing latent enhancers (44).
However, ligand activation of ER leads to thousands of
new binding sites in the genome within minutes (44). In
contrast, RXR occupies the genome of macrophages in
the steady state and works as a genome-bound lipid sen-
sor. Importantly, exogenous ligand addition is not neces-
sary for the IL-4-mediated extension of the RXR cistrome,
although we cannot exclude the role of endogenous ligands
here. Nonetheless, it appears to be the heterodimeric part-
ner, which has dominant effects on the positioning of RXR.
Upon polarization, STAT6 induces the level of PPAR ,
thus attracting RXR toDR1motifs in the genome. Surpris-
ingly,>60% of the STAT6-dependent de novoRXR sites are
established in a PPAR -dependent manner. The remain-
ing 40% may account for the effect of other transcription
factors downstream in the polarization process (secondary
wave), most likely EGR2 and AP-1. Importantly, the newly
deposited PPAR :RXR heterodimers contribute to the de-
velopment of the accessible chromatin profile of polarized
macrophages, although these factors are not indispensable
for de novo enhancer formation (Figure 6F).
Analysis of the binding kinetics of STAT6, RXR, PU.1,
P300 andRAD21 at de novoRXR sites revealed that STAT6
is the first recruited factor as expected, and followed by
PU.1, RXR, P300 and RAD21. The formation of de novo
RXR-bound enhancers is carried out by the direct and in-
direct actions of STAT6, including the induction of a sec-
ond wave of transcription factors like PPAR . Importantly,
RXR is not part of the ‘second wave’, because its protein
level is not changing and it is most likely recruited from
a non-chromatin-bound pool by STAT6 and its partner
PPAR or potentially by other polarization-specific tran-
scription factors. In addition, STAT6 directly affects the
extension of the RXR cistrome at those genomic regions,
which are primed by PU.1 and other regulatory factors at
the basal state.
As the polarization process is nearing completion, one
would expect that the newly established PPAR :RXR het-
erodimer cistrome confers vastly reprogrammed lipid re-
sponsiveness to the cells, but this is not exactly the case here.
It is important to note that we observed enhanced ligand
responsiveness on some of the ligand-sensitive genes in al-
ternatively polarized macrophages (Figure 6C) and though
there is a significant number of ligand-responsive genes,
which are predicted to control lipid metabolism, choles-
terol flux and uptake of fatty acids, the vast majority of
the PPAR :RXR-bound regulatory regions may work in
a ligand-independent manner and their functional impor-
tance is unknown.
Recently, we reported an unusual synergy between the ac-
tivating signals of RXR and STAT6. Interestingly, on a se-
lect set of genes ligand activation of RXR alone is not suf-
ficient to trigger gene activation, while STAT6 is capable of
doing so. Surprisingly, when both stimuli are present, syn-
ergistic gene activation was observed. These results suggest
the structural importance of ligand-bound RXR in facil-
itating another signaling pathway, but insufficient to drive
transcription alone (50). Themechanistic details of this phe-
nomenon remained enigmatic and will require additional
studies in our model as well.
The integrative approach used here allowed us to func-
tionally characterize the effects of the dominant ligands of
PPAR and RXR. As a result, we observed ligand-selective
gene sets from which we predicted ligand-specific cellular
functions (Figure 6F), which still attracts attention due to
the lack of knowledge about the genome-wide effects of nu-
clear receptor ligands.
Taken together, here we provide new molecular and
mechanistic insights into the polarization process of
macrophages and show that the dynamic reorganization of
the RXR heterodimer cistrome is a hallmark of this transi-
tion, leading to enhancer reprogramming and cistrome ex-
tension. The altered set of regulatory regions provides addi-
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tional options for the cells to extend their functional char-
acteristics and interact with their environment, but there
seems to be a large number of heterodimers that are inert
to exogenous ligand stimulation, which needs attention and
may lead to the reinterpretation of the mechanism of action
by nuclear receptors.
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